WO1994021603A1 - A process for preparing sulfones - Google Patents

A process for preparing sulfones Download PDF

Info

Publication number
WO1994021603A1
WO1994021603A1 PCT/US1993/012444 US9312444W WO9421603A1 WO 1994021603 A1 WO1994021603 A1 WO 1994021603A1 US 9312444 W US9312444 W US 9312444W WO 9421603 A1 WO9421603 A1 WO 9421603A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkali metal
sulfide
formula
equivalents
sulfone
Prior art date
Application number
PCT/US1993/012444
Other languages
French (fr)
Inventor
Kevin Scott Webb
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Priority to AU58535/94A priority Critical patent/AU5853594A/en
Priority to EP94904512A priority patent/EP0675877A4/en
Priority to JP6515524A priority patent/JPH08505151A/en
Publication of WO1994021603A1 publication Critical patent/WO1994021603A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides

Definitions

  • Rj is Cg to Ci3-alkyl, C7 to C- -alkoxy, unsubstituted or substituted phenyl-C4 to Cio-alkyl- unsubstituted or substituted phenyl-C3 to Ctp-alkoxy with substituted phenyl is substituted with bromo, chloro, trifluoromethyl, or Cj to C -alkoxy
  • R is -(CH2) n ArA or ArA where n is 0-6, Ar is phenyl or substituted phenyl, and A is - (CH2) n R2- where n is 0-6.
  • R2 is -COOH or CO2X where X is an alkali metal cation
  • Y is R2 or -CH(R3)(CH2) m R2. and R3 is hydrogen, methyl, C ⁇ to C4 alkoxy, fluoro or hydroxy; wherein the process comprises i. preparing an aqueous alkali metal salt solution of an acid of formula A;
  • phenyl or naphthyl group can be present.
  • Naphthyl is represented by the use of a dotted outline with a circle in the center, that portion of formulas I and A may be absent, giving the phenyl or may be present giving the naphthyl radical.
  • This invention is intended to cover both sets of compounds.
  • the sulfides of formula A can be found in the literature, particularly in the patent literature.
  • Compounds where R is an alkyl acid are disclosed in U.S. patent numbers 4,820,719 and 4,874,792.
  • Formula A compounds where R is a 5-membered heterocyclic ring group are disclosed in U.S. patent number 5,135,938.
  • Sulfides where R is a six-membered aiyl or heteroaryl group are disclosed in European Patent Application No. 90306438.4.
  • Compounds where the dotted lines denotes naphthyl can be found in European Patent Application 91908637.1. All are incorporated herein by reference in full as if set out here.
  • the compound of most interest in this invention is that one where R is the 4- carboxyphenyl group. How to make these sulfides is disclosed in European Patent Application 91908637.1.
  • the oxidation of most interest here is that of converting the sulfide (R*,S*)- ⁇ [(4- c_-rboxyphenyl)thio)- ⁇ -methoxy-2-(8-phenyloctyl)benzene propanoic acid to its corresponding sulfone, the (R*,S*)-p ⁇ [(4-carboxyphenyl)sulfonyl)- ⁇ -methoxy-2-(8-phenyloctyl)benzene propanoic acid. Bodi of these compounds are disclosed in EP application 91908637.1. In that application the sulfone was prepared by treating the sulfide with about two equivalents of m- perchlorobenzoic acid.
  • an aqueous solution of the sulfide in the form of an alkali metal salt is first prepared. This can be done by simply dissolving an existing alkali metal salt in water or by dissolving die free acid in a solution of an alkali metal base, eg. an alkali metal hydroxide. !£ the f. ⁇ re acid is being dissolved in base, at minimum two equivalents of base should be used, it is preferable to use at least one equivalent of base per acidic function in the molecule, an excess of base is preferred so that complete ionization of all acid groups is achieved. As the cation, the preferred ion is sodium. Sodium hydroxide is the preferred alkali metal hydroxide.
  • a buffering agent is added to adjust die pH.
  • a bicarbonate ion is preferred, particularly the bicarbonate which has the same cation as that of the sulfide salt
  • sodium bicarbonate is preferred.
  • Bicarbonate is added in an amount sufficient to buffer the solution to a pH between about 7.0 and 8.5, preferably 7.5 to 8.0.
  • a co-solvent in the form of a water-miscible ketone is then added in an amount between 10 and 15%.
  • Simple ketones such as dimethyl or diethyl ketone may be used.
  • the preferred ketone is acetone.
  • a preferred amount is that of about 12.5%.
  • Oxone® (potassium peroxymonosulfate) is then added.
  • This oxidant is commercially available from several suppliers, for example Aldrich Chemical Company, U.S.A.
  • An excess of Oxone® is added. Preferably that excess will be in the range of 1.1 to 1.5 equivalents, though it will be appreciated that an amount exceeding 1.5 equivalents could be used though such added quantities likely would not achieve much in the way of a cost effective transformation of the sulfide to the sulfone.
  • An optimized quantity is believed to be about 1.35 equivalent of Oxone®.
  • One of the attributes of this improved process is that an elevated temperature is not required to effect the reaction. The reaction can be carried out at ambient temperature or thereabouts. An effective range is anywhere from about 10°C to 50° C.
  • the reaction can be quenched by adding a reducing agent, eg. sodium bisulfite, and die sulfone recovered as the salt.
  • a reducing agent eg. sodium bisulfite, and die sulfone recovered as the salt.
  • die solution can be made acidic and by that means the free acid formed; it may be then recovered by any means desired.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Certain sulfides can be converted to sulfoxides or sulfones using oxone in 12.5 % aqueous acetone and buffered to pH 7.5 - 8.0 with sodium bicarbonate.

Description

A PROCESS FOR PREPARING SULPONES
Scope of the Invention
Sulfides have been converted to sulfoxides or sulfones using Oxone® in an water ketone co-solvent system buffered to pH of about 7.5 - 8.0 with a bicarbonate. Background
The peptidic leukotrienes LTC4, LTD4 and LTE4 which comprise a special class of arachidonic acid metabolites have been shown to play important roles in cell and tissue biology. In particular, these leukotrienes (C4, D4 and E4) are now believed to be directly involved in a variety of immediate hypersensitivity diseases, among these allergic asthma. A new peptidoleukotriene receptor antagonist, (R*,S*)-β-[(4-carboxyphenyl)sulfonyl)-α-methoxy-2- (8-phenyloctyl)benzene propanoic acid has been discovered and subsequendy chosen as a candidate for the treatment of bronchial asthma. This compound and how to make it is disclosed in European Patent Application No. 90306438.4 published where the sulfide was first made, then treated with -perchlorobenzoic acid to obtain the sulfone. The reaction is illustrated in Scheme I.
Sciismsl
Figure imgf000003_0001
Synthetic scale-up for new drug testing efforts lead to a search for new methods for oxidizing the sulfide to the sulfone. Although many chemical reagents are known in the literature for this type of oxidation, each appeared unacceptable for the synthesis of kilogram quantities of compounds of this general structural type. What was needed was an oxidation which was amenable to scale-up, operationally simple to perform, and environmentally sound. Several oxidation procedures were investigated in hopes of finding the optimal conditions for this class of compounds. The following approaches were investigated:
The use of sodium tungstate dihydrate in the presence of 30% hydrogen peroxide was attempted. It gave a mixture of sulf oxide and sulfone (3:1) and prolonged heating (60° C) (insert reference) produced a major undesired impurity as evident by HPLC (25% (PAR)). Alternately, Ammonium molybdate (VI) tetrahydrate and 30% hydrogen peroxide [Amarel, M.J. J. Chem. Soc. (c) 1969, 2495] was found to be a rather sluggish reaction. After 96 hours at ambient temperature the reaction was incomplete with 16% of the intermediate sulfoxide remaining. This same reaction at elevated temperatures was unsuccessful, the desired product was found to be unstable to the reaction conditions. Sodium perborate in glacial acetic acid (McKillop, A.; Tarbin, J.A. Tetrahedron Lett. 1983, 24(14), 1505.) proved to be an effective and useful procedure for synthesizing small quantities of the sulfone. However, the physical properties of the drug substance rendered the use of sodium perborate in glacial acetic acid unacceptable for kilogram conversions. Several permutations on the reaction conditions were investigated in hopes of obtaining a workable and reliable procedure, but the replacement of acetic acid by formic acid (88% or 96%) or by 50% aqueous methanol (under acid catalyst) were ineffective in producing a clean conversion of sulfide to sulfone.
Oxone® in 50% aqueous methanol [Trost, B.M.; Curran, D.P. Tetrahedron Lett. 1990, 31(26), 3685] or 50 % aqueous acetone [Volkmann, R.A.; Kelbaugh, P.R.; Nason, D.M.; Jasys, V.J. J. Org. Chem.1992, 57, 4352] has been used for sulfide oxidations, but was not a useful procedure for the oxidation of the sulfone of interest here. A phase transfer catalyst, gende heating (55° C) and excess oxidant were required to produce the desired sulfone in only 65 to 70% isolated yields of inconsistent purity. The use of tetra-Λ-butylammonium oxone (Trost, MM.; Braslau, R. J. Org. Chem. 1988, 53,532) was deemed impractical due to the large amount of solids needed to produce this salt
Attempts to find a process which would provide a salt form acceptable to regulatory agencies, led to the finding that a carbonate buffered aqueous system using a co-solvent provided great success. The results were an oxone-based oxidation system using a carbonate to buffer the pH and a ketone as the co-solvent. No epimerization was observed under the reaction conditions, and also no elimination of the sulfonyl acid moiety leading to cinnamic acid derivatives occurred.
Summary of the Invention A process for preparing a sulfone of formula I:
Figure imgf000004_0001
where the dotted lines indicate a second aromatic ring forming naphthyl may be present,
Rj is Cg to Ci3-alkyl, C7 to C- -alkoxy, unsubstituted or substituted phenyl-C4 to Cio-alkyl- unsubstituted or substituted phenyl-C3 to Ctp-alkoxy with substituted phenyl is substituted with bromo, chloro, trifluoromethyl, or Cj to C -alkoxy
R is -(CH2)nArA or ArA where n is 0-6, Ar is phenyl or substituted phenyl, and A is - (CH2)nR2- where n is 0-6.
R2 is -COOH or CO2X where X is an alkali metal cation,
Y is R2 or -CH(R3)(CH2)mR2. and R3 is hydrogen, methyl, C\ to C4 alkoxy, fluoro or hydroxy; wherein the process comprises i. preparing an aqueous alkali metal salt solution of an acid of formula A;
Figure imgf000005_0001
ii. buffering said solution to a pH of between 7 - 8.5 using an alkali metal bicarbonate; iii. adding a ketone co-solvent in an amount between 10 and 15% by volume relative to the water, iv. adding between 1 and 1.5 equivalents of Oxone®; and v. running the reaction for between 30 minutes and 2 hours at a temperature between 10° and 50° C.
In formula I and formula A, either the phenyl or naphthyl group can be present. Naphthyl is represented by the use of a dotted outline with a circle in the center, that portion of formulas I and A may be absent, giving the phenyl or may be present giving the naphthyl radical. This invention is intended to cover both sets of compounds.
The sulfides of formula A can be found in the literature, particularly in the patent literature. Compounds where R is an alkyl acid are disclosed in U.S. patent numbers 4,820,719 and 4,874,792. Formula A compounds where R is a 5-membered heterocyclic ring group are disclosed in U.S. patent number 5,135,938. Sulfides where R is a six-membered aiyl or heteroaryl group are disclosed in European Patent Application No. 90306438.4. Compounds where the dotted lines denotes naphthyl can be found in European Patent Application 91908637.1. All are incorporated herein by reference in full as if set out here. The compound of most interest in this invention is that one where R is the 4- carboxyphenyl group. How to make these sulfides is disclosed in European Patent Application 91908637.1. The oxidation of most interest here is that of converting the sulfide (R*,S*)-β[(4- c_-rboxyphenyl)thio)-α-methoxy-2-(8-phenyloctyl)benzene propanoic acid to its corresponding sulfone, the (R*,S*)-p^[(4-carboxyphenyl)sulfonyl)-α-methoxy-2-(8-phenyloctyl)benzene propanoic acid. Bodi of these compounds are disclosed in EP application 91908637.1. In that application the sulfone was prepared by treating the sulfide with about two equivalents of m- perchlorobenzoic acid.
In this process, an aqueous solution of the sulfide in the form of an alkali metal salt is first prepared. This can be done by simply dissolving an existing alkali metal salt in water or by dissolving die free acid in a solution of an alkali metal base, eg. an alkali metal hydroxide. !£ the f. re acid is being dissolved in base, at minimum two equivalents of base should be used, it is preferable to use at least one equivalent of base per acidic function in the molecule, an excess of base is preferred so that complete ionization of all acid groups is achieved. As the cation, the preferred ion is sodium. Sodium hydroxide is the preferred alkali metal hydroxide. Next a buffering agent is added to adjust die pH. A bicarbonate ion is preferred, particularly the bicarbonate which has the same cation as that of the sulfide salt Herein sodium bicarbonate is preferred. Bicarbonate is added in an amount sufficient to buffer the solution to a pH between about 7.0 and 8.5, preferably 7.5 to 8.0.
A co-solvent in the form of a water-miscible ketone is then added in an amount between 10 and 15%. Simple ketones such as dimethyl or diethyl ketone may be used. The preferred ketone is acetone. A preferred amount is that of about 12.5%. These figures are measured on a volume/volume basis.
Oxone® (potassium peroxymonosulfate) is then added. This oxidant is commercially available from several suppliers, for example Aldrich Chemical Company, U.S.A. An excess of Oxone® is added. Preferably that excess will be in the range of 1.1 to 1.5 equivalents, though it will be appreciated that an amount exceeding 1.5 equivalents could be used though such added quantities likely would not achieve much in the way of a cost effective transformation of the sulfide to the sulfone. An optimized quantity is believed to be about 1.35 equivalent of Oxone®. One of the attributes of this improved process is that an elevated temperature is not required to effect the reaction. The reaction can be carried out at ambient temperature or thereabouts. An effective range is anywhere from about 10°C to 50° C. While temperatures in excess of 50°C could be used, there is no perceived benefit in doing so, given that the reaction proceeds to completion with very high yields at ambient temperature in 1 to 2 hours. In each of the foregoing steps, some form of mixing or stirring can be used as part of the process of carrying out this invention.
After the period allowed for the reaction to go to completion, which can be monitored by some means such as by chromotography, the reaction can be quenched by adding a reducing agent, eg. sodium bisulfite, and die sulfone recovered as the salt. Alternatively, after the reaction is quenched, die solution can be made acidic and by that means the free acid formed; it may be then recovered by any means desired.
The following example is provided to illustrate the invention. It is not indented to limit the invention in any manner. Reference is made to the claims for what is reserved to the inventor. Examples Example 1 Preparation of (R*.S*Vβ-. (4-carboxvphenvl ■sulfonvl-α-me.hoxv-2-f8- phenyloctyl'.benzene propanoic acid To a 500 mL round bottom flask equipped with a magnetic stir bar was charged 1.67 g of sodium hydroxide and 30 mL of dionized water. To the vigorously stirred basic solution was added 9.5 g of (R*,S*)-β-[(4-carboxyphenyl)thio)-α-methoxy-2-(8-phenyloctyl)benzene propanoic acid. The suspension was vigorously stirred at ambient temperature for 20 minutes producing a light yellow solution. To this was added 12.50 g of sodium bicarbonate and 10 mL of acetone. The Oxone® solution (15.00 g in 40 mL of 4X10- M EDTA) was quickly added over 5 minutes. The resulting suspension was vigorously stirred for 1 2 hour at ambient temperature. A sample was removed and analyzed by HPLC. The reaction was quenched with sodium bisulfite (9.20 g in 18 mL of deionized water) and stirred for 15 minutes. To the solution was charged 200 mL of ethyl acetate and acidified to pH 2 with 35 mL of 6N (aq) HCl. The organic layers were combined and washed 2 X 75 mL with deionized water, 1 X 75 mL with brine, dried over anhydrous NA2SO4, filtered and concentrated via rotovap. The thick oil was placed on d e vacuum pump (0.5 torr) for 48 hours and heated to 60° C to give 9.44 grams (94.07%) of the captioned product
This same process can be used to oxidize any of the sulfides of formula A to the sulfones of formula I.

Claims

What is claimed is:
1. A process for preparing a sulfone of formula I:
Figure imgf000008_0001
where the dotted lines indicate a second aromatic ring forming naphthyl,
Rj is Cg to Ci3-alkyl, C7 to C- -alkoxy, unsubstituted or substituted phenyl-C4 to Cjo-alkyl, unsubstituted with bromo, chloro, trifluoromethyl, or C\ to C4-alkoxy
R is -(CH2)nA, -(CH2)nArA where n is 0-6, Ar is phenyl or substituted phenyl, and A is -(CH2)nR2» where n is 0-6. R2 i -COOH or CO2X where X is an alkali metal cation,
Y is R2 or -CH(R3)(CH2)mR2; and R3 is hydrogen, methyl, C\ to C4 alkoxy, fluoro or hydroxy; wherein the improvement comprises: i. preparing an aqueous alkali metal salt solution of an acid of formula A;
Figure imgf000008_0002
ϋ. buffering said solution to a pH of between 7 - 8.5 using an alkali metal bicarbonate; iii. adding a ketone co-solvent in an amount between 10 and 15% by volume relative to the water, iv. adding between 1 and 1.5 equivalents of Oxone®; and v. running the reaction for between 30 minutes and 2 hours at a temperature between 10° C and 50° C.
2. The process of claim 1 where the alkali metal hydroxide is NaOH.
3. The process of claim 3 where the alkali metal bicarbonate is sodium bicarbonate and die pH range is 7.5 - 8.0.
4. The process of claim 2 where the ketone is acetone.
5. The process of claim 4 where the sulfide of formula I has a phenyl group and R is 4-carboxyphenyl.
6. The process of claim 5 for oxidizing the sulfide (R*,S*)-β-[(4- carboxyphenyl)thio)-α-methoxy-2-(8-phenyloctyl)benzene propanoic acid, to the sulfone (R*,S*)-β-[(4-carboxyphenyl)sulfonyl)-α-methoxy-2-(8-phenyloctyl)benzene propanoic acid, which process comprises: i. dissolving the sulfide dissolved in water containing 2.1 equivalents of NaOH, ϋ. adding an excess of sodium bicarbonate, iii. adding acetone in an amount sufficient to make 12.5% acetone/water solution (volume/Volume), iv. adding 1.35 equivalents of Oxone®, and v. stirring said mixture for 1 hour at ambient temperature.
PCT/US1993/012444 1992-12-23 1993-12-21 A process for preparing sulfones WO1994021603A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU58535/94A AU5853594A (en) 1992-12-23 1993-12-21 A process for preparing sulfones
EP94904512A EP0675877A4 (en) 1992-12-23 1993-12-21 A process for preparing sulfones.
JP6515524A JPH08505151A (en) 1992-12-23 1993-12-21 Method for producing sulfone

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99634292A 1992-12-23 1992-12-23
US07/996,342 1992-12-23

Publications (1)

Publication Number Publication Date
WO1994021603A1 true WO1994021603A1 (en) 1994-09-29

Family

ID=25542798

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/012444 WO1994021603A1 (en) 1992-12-23 1993-12-21 A process for preparing sulfones

Country Status (7)

Country Link
EP (1) EP0675877A4 (en)
JP (1) JPH08505151A (en)
CN (1) CN1100092A (en)
AU (1) AU5853594A (en)
MX (1) MX9400081A (en)
WO (1) WO1994021603A1 (en)
ZA (1) ZA939517B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006118322A1 (en) * 2005-04-28 2006-11-09 Shiratori Pharmaceutical Co., Ltd. Method for producing hydrazone derivatives
US8178670B2 (en) 2008-01-07 2012-05-15 Biomarin Pharmaceutical Inc. Method of synthesizing tetrahydrobiopterin
US8901311B2 (en) 2002-07-03 2014-12-02 Makhteshim Chemical Works, Ltd. Method for producing heterocyclic fluoroalkenyl sulfones

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102241616A (en) * 2010-05-12 2011-11-16 利尔化学股份有限公司 Preparation method of sulfones
CN103450058B (en) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 A kind of preparation method of amisulpride acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403249A1 (en) * 1989-06-14 1990-12-19 Smithkline Beecham Corporation Leukotriene antagonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403249A1 (en) * 1989-06-14 1990-12-19 Smithkline Beecham Corporation Leukotriene antagonists

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Journal of Organic Chemistry, Vol. 57, issued 1992, VOLKMANN et al., "2 Thioalkyl Penems: An Efficient Synthesis of Sulopenem, a (5R.6s)-6(1(R)-Hydroxyethyl)-2-((cis-1-oxo- 3-thiolanyl)thio)-2- penem Antibacterial", pages 4352-4361, see entire document. *
See also references of EP0675877A4 *
Tetrahedron Letters, Vol. 22, No. 14, issued 1981, TROST et al., "Chemoselective Oxidation of Sulfides to Sulfones with Potassium Hydrogen Persulfate", pages 1287-1290. *
Tetrahedron Letters, Vol. 31, No. 26, issued 1990, QUALLICH et al., "Diastereoselective Oxidation of Sulfides to Sulfoxides with Potassium Peroxymonosulfate", pgs. 3685-3686; see entire document. *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8901311B2 (en) 2002-07-03 2014-12-02 Makhteshim Chemical Works, Ltd. Method for producing heterocyclic fluoroalkenyl sulfones
WO2006118322A1 (en) * 2005-04-28 2006-11-09 Shiratori Pharmaceutical Co., Ltd. Method for producing hydrazone derivatives
US7582799B2 (en) 2005-04-28 2009-09-01 Shiratori Pharmaceutical Co., Ltd. Method for producing hydrazone derivatives
AU2006241673B2 (en) * 2005-04-28 2011-02-24 Daiichi Sankyo Company, Limited Method for producing hydrazone derivatives
KR101277074B1 (en) 2005-04-28 2013-06-25 다이이찌 산쿄 가부시키가이샤 Method for producing hydrazone derivatives
US8178670B2 (en) 2008-01-07 2012-05-15 Biomarin Pharmaceutical Inc. Method of synthesizing tetrahydrobiopterin

Also Published As

Publication number Publication date
AU5853594A (en) 1994-10-11
ZA939517B (en) 1995-01-31
EP0675877A1 (en) 1995-10-11
CN1100092A (en) 1995-03-15
JPH08505151A (en) 1996-06-04
EP0675877A4 (en) 1996-07-31
MX9400081A (en) 1994-07-29

Similar Documents

Publication Publication Date Title
EP2042497B1 (en) Method for producing strontium ranelate and its hydrates
JP5042843B2 (en) Production method of hydrazones
US6603009B2 (en) Method for oxidizing a thioether group into a sulfoxide group
JPH05502232A (en) Method for producing sclareolide
EP0675877A1 (en) A process for preparing sulfones
JPH0150704B2 (en)
US7244865B2 (en) Process for preparing benzhydrylthioacetamide
JP4351626B2 (en) Method for producing modafinil
EP1678129B1 (en) Improved process for preparing benzhydrylthioacetamide
US4966731A (en) Process for preparing sulfonyl acids
EP1919863A1 (en) Process for the production of bicalutamide
HU183697B (en) Process for preparing saccharine
KR20070114343A (en) Process for preparation of bicalutamide
JP2003508521A (en) Method for producing 1-substituted 5-hydroxymethylimidazole
EP0539451B1 (en) Vinylsulphonyl pristinamycin and preparation thereof
JPS60169493A (en) Preparation of 5-deoxy-l-arabinose
FR2564834A1 (en) PROCESS FOR THE PREPARATION OF ALKYL 3-CHLOROSULFONYLTHIOPHENE-2-CARBOXYLATE
JP3159767B2 (en) Novel sulfur-containing compound and method for producing the same
KR100518933B1 (en) Method for purifying Oxazoline- azetidinone derivative
CN117924129A (en) Preparation method of sulfone and sulfoxide compounds
KR20040092058A (en) Manufacture method of Erdosteine
JP2001064279A (en) New selenium compound
JPH047738B2 (en)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR BY CA CZ FI HU JP KP KR KZ LK LV MG MN MW NO NZ PL RO RU SD SK UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1994904512

Country of ref document: EP

ENP Entry into the national phase

Ref country code: US

Ref document number: 1995 464780

Date of ref document: 19950621

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1994904512

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1994904512

Country of ref document: EP